TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 EUR)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
42
|
32
|
23 |
| Financial expenses |
0
|
0
|
6 |
| Earnings before taxes |
20
|
2
|
192 |
| EBITDA |
5
|
-3
|
1 |
| Total assets |
623
|
577
|
636 |
| Current assets |
586
|
542
|
596 |
| Current liabilities |
15
|
7
|
6 |
| Equity capital |
601
|
564
|
621 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
96.5%
|
97.7%
|
97.6% |
| Turnover per employee |
42
|
32
|
23 |
| Profit as a percentage of turnover |
47.6%
|
6.2%
|
834.8% |
| Return on assets (ROA) |
3.2%
|
0.3%
|
31.1% |
| Current ratio |
3906.7%
|
7742.9%
|
9933.3% |
| Return on equity (ROE) |
3.3%
|
0.4%
|
30.9% |
| Change turnover |
9
|
12
|
-16 |
| Change turnover % |
26%
|
57%
|
-41% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.